Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 11 studies | 42% ± 15% | |
fibroblast | 9 studies | 33% ± 15% | |
oligodendrocyte precursor cell | 6 studies | 27% ± 11% | |
Mueller cell | 5 studies | 44% ± 5% | |
endothelial cell | 5 studies | 40% ± 24% | |
podocyte | 4 studies | 57% ± 18% | |
plasma cell | 4 studies | 26% ± 6% | |
astrocyte | 4 studies | 33% ± 11% | |
kidney loop of Henle epithelial cell | 4 studies | 24% ± 6% | |
retinal cone cell | 3 studies | 34% ± 12% | |
rod bipolar cell | 3 studies | 24% ± 7% | |
type II pneumocyte | 3 studies | 20% ± 1% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 28% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 6621.49 | 89 / 89 | 91% | 10.89 | 821 / 901 |
thymus | 100% | 4908.19 | 653 / 653 | 87% | 12.37 | 525 / 605 |
prostate | 99% | 2109.90 | 242 / 245 | 62% | 2.74 | 313 / 502 |
lung | 98% | 2139.67 | 566 / 578 | 61% | 6.45 | 703 / 1155 |
pancreas | 93% | 795.98 | 305 / 328 | 56% | 3.15 | 99 / 178 |
adrenal gland | 100% | 2913.98 | 258 / 258 | 17% | 0.77 | 40 / 230 |
bladder | 86% | 963.48 | 18 / 21 | 21% | 1.24 | 106 / 504 |
heart | 98% | 2454.49 | 846 / 861 | 0% | 0 | 0 / 0 |
spleen | 98% | 1007.27 | 235 / 241 | 0% | 0 | 0 / 0 |
esophagus | 62% | 666.72 | 903 / 1445 | 32% | 2.59 | 59 / 183 |
muscle | 95% | 1510.87 | 760 / 803 | 0% | 0 | 0 / 0 |
ovary | 88% | 997.16 | 159 / 180 | 6% | 0.27 | 26 / 430 |
stomach | 65% | 421.86 | 235 / 359 | 28% | 1.73 | 81 / 286 |
uterus | 71% | 925.09 | 121 / 170 | 16% | 1.24 | 72 / 459 |
blood vessel | 74% | 2347.85 | 988 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 3.35 | 20 / 29 |
brain | 23% | 117.36 | 595 / 2642 | 35% | 1.88 | 246 / 705 |
breast | 36% | 241.82 | 164 / 459 | 17% | 0.74 | 194 / 1118 |
intestine | 36% | 383.63 | 346 / 966 | 16% | 0.99 | 83 / 527 |
liver | 28% | 165.95 | 64 / 226 | 22% | 1.21 | 91 / 406 |
tonsil | 0% | 0 | 0 / 0 | 49% | 6.37 | 22 / 45 |
skin | 30% | 603.50 | 543 / 1809 | 19% | 0.75 | 88 / 472 |
adipose | 32% | 281.42 | 387 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 17% | 247.71 | 159 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.09 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032836 | Biological process | glomerular basement membrane development |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005587 | Cellular component | collagen type IV trimer |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | COL4A4 |
Protein name | Collagen type IV alpha 4 chain Collagen alpha-4(IV) chain |
Synonyms | |
Description | FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. |
Accessions | P53420 A0A804HI86 ENST00000682098.1 A0A804HI71 ENST00000683508.1 ENST00000396625.5 A0A804HLF6 A0A2R8Y548 ENST00000643379.1 ENST00000684524.1 |